Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.
about
Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency.A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo.IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.Targeting tumour microenvironment by tyrosine kinase inhibitor.Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
P2860
Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@en
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@nl
type
label
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@en
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@nl
prefLabel
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@en
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@nl
P2093
P2860
P356
P1433
P1476
Multikinase inhibitor regorafe ...... n cancer with abundant stroma.
@en
P2093
Hidehiko Takigawa
Kazuaki Chayama
Kei Shinagawa
Shinji Tanaka
Wataru Yasui
Yasuhiko Kitadai
Yukihito Higashi
P2860
P304
P356
10.1111/CAS.12907
P577
2016-02-10T00:00:00Z